PMV Pharmaceuticals, Inc.
NASDAQPMV Pharmaceuticals heads into its May 15 earnings print having dropped 9% in a single session Wednesday, with short sellers building positions at the fastest monthly rate in recent memory. The most striking feature of the setup is how aggressively shorts have accumulated over the past month. Short interest has climbed roughly 71% over the past 30 days to nearly 4.8% of the free…
Snapshot as of 14 May 2026
PMV Pharmaceuticals heads into its May 15 earnings print having dropped 9% in a single session Wednesday, with short sellers building positions at the fastest monthly rate in recent memory. The most striking feature of…
PMV Pharmaceuticals heads into its May 15 investor call with a conflicting set of signals: a Q1 earnings beat, a short-interest spike, and fresh analyst caution. The most notable piece of recent Street activity came…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PMVP — free to start on ORTEX.
Sign up for free →Open PMVP on ORTEX